Huntsman Cancer Institute (HCI) at the University of Utah is a cancer research and treatment center. HCI is a National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, which means it meets the highest standards for cancer care and research and receives support for its scientific endeavors. Learn more about our Cancer Center Research Programs. HCI is also a member of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of the world’s leading cancer centers. NCCN is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

Mission Statement 

Huntsman Cancer Institute's mission is to understand cancer from its beginnings, to use that knowledge in the creation and improvement of cancer treatments, to relieve the suffering of cancer patients, and to provide education about cancer risk, prevention, and care. 

Hope Through Research

HCI scientists focus on understanding cancer from its beginnings to create safer and more effective treatments. Researchers also investigate how genes function to discover possible methods of preventing, circumventing, or even reversing the genetic changes that cause cancer.

Hope Through Education

HCI offers free information about cancers, risk factors, screening, prevention, and treatments to patients, family members, physicians, and the public.

Hope Through Care

At HCI, teams of doctors and health care professionals work together to provide compassionate, state-of-the-art care.

Our Patient Reach

HCI serves thousands of cancer patients throughout every year and provides academic and clinical training for future physicians and researchers. Most of our patients come from Utah, a state that covers more than 80,000 square miles, of which 96% is rural (<100 people/square mile) and 70% is frontier (<7 people/square mile). Utah is also home to seven Native American tribes or nations.

Although Utah is our primary catchment area, patients are referred from a broad, multistate region of the Mountain West that includes portions of Idaho, Montana, Nevada, and Wyoming—an area rich in special populations that are historically underserved and exhibit poor cancer outcomes compared to the U.S. average.

HCI is committed to equity in research opportunities for all genders and minority groups in our catchment area. We ensure every person receives excellent cancer care and is able to benefit from the latest advances in cancer diagnosis, treatment, and prevention strategies through participation in clinical trials.

Recent News

Living with Cancer

Creating Your New Normal after a Cancer Diagnosis

Cancer can be a life-altering experience for patients and their loved ones. Recovering your sense of who you are and how you will live your life going forward are important aspects of your recovery and survivorship.

Read More

In The Media

Scientists See Progress for Cancer Vaccines

Tumor-destroying vaccines have emerged as a new weapon in the fight against cancer. Conventional vaccines prevent people from getting sick in the first place. Now scientists are testing a new type of vaccine that treats existing cancers by spurring immune cells to go on the attack. These drugs—known as therapeutic vaccines—hold the potential to plunge cancers into remission without causing the side effects of treatments such as chemotherapy.

Read More